関連する実験動画
Updated: Dec 3, 2025
07:35
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
13.2K
保存されたエジェクション分子の心不全における心筋膜遺伝子発現シグネチャー
Virginia S Hahn1, Hildur Knutsdottir2, Xin Luo3
1Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD (V.S.H., J.V., D.A.K., K.S.).
Circulation
|October 29, 2020
まとめ
HFpEF (保存されたエジェクション分数による心不全) は独特の分子シグネチャーを持っています. 異なるHFpEFサブグループを特定することで,この困難な心臓病の新たな治療目標が明らかになります.
科学分野:
- 心臓病科
- 分子生物学
- ゲノミクス
背景:
- HFpEF (保存されたエジェクション分数を持つ心不全) は,すべての心不全症例の半分を占めるが,効果的な治療法がない.
- 心臓組織の限られた分子分析は,HFpEFの心筋生物学の理解を妨げます.
研究 の 目的:
- HFpEF患者の心臓組織に包括的なトランスクリプトミア分析を行う.
- HFpEF内の分子サブグループを特定し,臨床的および血液動力学的データと相関させる.
- HFpEFのトランスクリプトミックのプロフィールと心不全の低射出分数 (HFrEF) と健康なコントロールを比較する.
主な方法:
- HFpEF (n=41),HFrEF (n=30) およびドナー対照群の内臓組織生検でRNA配列を決定した.
- 主要成分分析と階層的なクラスタリングは,トランスクリプトミックの特徴とグループ分離を評価するために使用されました.
- 非負のマトリックス因数分解と加重遺伝子共表現ネットワーク解析により,HFpEF内の分子サブグループが特定されました.
主要な成果:
- トランスクリプトミックの分析では,併発症を調整した後でも,HFpEFとHFrEFとコントロールを明確に分離しました.
- HFpEFは遺伝子発現パターンが独特で,ミトコンドリア経路が上昇し,エンドプラズマ網膜のストレス/オートファギーの経路が低下した.
- 特定の臨床的特徴と死亡リスクと相関する3つの異なるHFpEF分子サブグループが特定されました.
結論:
- HFpEFは,独特のトランスクリプトミカルシグネチャーと,異なる臨床的特徴とアウトカムに関連した分子サブグループを示しています.
- これらの発見は,HFpEF内の新しいシグナル伝達経路と分子サブグループを強調し,精密医療の潜在的なターゲットを示唆しています.
関連する概念動画
01:17Pathophysiology of Heart Failure
2.3K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.3K
01:29Heart Failure II: Pathophysiology
441
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
441
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
224
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
224
01:30Cardiomyopathy II: Dilated Cardiomyopathy
253
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
253
01:26Heart Failure III: Clinical Manifestations
272
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
272
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
286
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
286